Clinical trials
Withdrawn Small Cell Lung Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 2 |
| AbbVie | 1 |
| Addario Lung Cancer Medical Institute | 1 |
| CytRx | 1 |
| John Villano | 1 |
| Mark M. Fuster, MD | 1 |
| Massachusetts General Hospital | 1 |
| National Cancer Institute (NCI) | 1 |
| University of Maryland, Baltimore | 1 |
| University of Southern California | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 11 |
| Lung Neoplasms | 4 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Neoplasm Metastasis | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Small Cell | 1 |
| Lambert-Eaton Myasthenic Syndrome | 1 |
| Mesothelioma, Malignant | 1 |
| Neuroendocrine Tumors | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.